TITLE

Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic—spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibody

AUTHOR(S)
Tanaka, Masami; Tanaka, Keiko; Komori, Mika; Saida, Takahiko
PUB. DATE
September 2007
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep2007, Vol. 78 Issue 9, p990
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Anti-aquaporin 4 (AQP4) antibodies were found in patients with neuromyelitis optica (NMO) and Japanese optic—spinal multiple sclerosis (OSMS). Objective: To review the clinical features and investigate anti-AQP4 antibodies of Japanese patients with multiple sclerosis (MS), with or without long spinal cord lesions (LCL). Methods: Anti-AQP4 antibodies were examined in the sera of 128 consecutive Japanese patients by the immunofluorescence method using AQP4 transfected cells. Results: The 45 LCL-MS patients included 28 with a long spinal cord lesion extending contiguously over three vertebral segments on sagittal 12 weighted images (long 12 lesion) and 17 with segmental cord atrophy extending more than three vertebral segments. We identified 25 patients with anti-AQP4 antibody with LCL and anti-AQP4 antibody. Anti-AQP4 antibody was found in 12/17 (70.6%) [CL-MS patients with segmental cord atrophy, and in 13/28 (46.4%) [CL-MS patients without segmental long cord atrophy (p=0.13.5, Fisher's exact test). Seropositive MS patients with [CL had more relapses than seronegative patients (p=0.0004, Mann- Whitney U test). 9 patients with OSMS were negative for anti- AQP4 antibody who did not show [CL. Conclusion: These results suggest that an anti-AQP4 antibody is found not only in MS patients with long 12 lesions but also in patients with segmental cord atrophy extending more than three vertebral segments. It is a marker of [CL-MS showing frequent exacerbations. Japanese OSMS cases comprised those that were identical to NMO cases and those that were more closely related to classic MS.
ACCESSION #
26437283

 

Related Articles

  • Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Barnett, MH; Prineas, JW; Buckland, ME; Parratt, JDE; Pollard, JD // Multiple Sclerosis Journal;Jan2012, Vol. 18 Issue 1, p108 

    Auto-antibody mediated astrocyte injury is implicated as a primary event in neuromyelitis optica (NMO) by biomarker, post-mortem and experimental studies that differentiate the condition from multiple sclerosis. We describe the clinical, radiological and neuropathological features of a severe...

  • Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders. Kim, Sung-Min; Waters, Patrick; Woodhall, Mark; Kim, Jee-Young; Kim, Jee-Eun; Yang, Ji Won; Kim, Jun-Soon; Sung, Jung-Joon; Park, Kyung Seok; Lee, Kwang-Woo // Multiple Sclerosis Journal;Jul2013, Vol. 19 Issue 8, p1060 

    The article presents a study which evaluates the utility of aquaporin-4 antibodies (AQP4-Ab) in patients with neuromyelitis optica spectrum disorders (NMOSD). It notes that the radiological and clinical features of 78 patients with NMOSD and 22 with multiple sclerosis (MS) who were examined with...

  • Distinction of Neuromyelitis Optica from Multiple Sclerosis: The Role of Anti-aquaporin-4 Antibody. Abdeldayem, Sabry M.; Fathy, Sabry M.; Awad, Eman M.; Hussein, Wael R.; EL-Wakil, Sahar // Egyptian Journal of Neurology, Psychiatry & Neurosurgery;Jul2012, Vol. 49 Issue 3, p251 

    Background: Neuromyelitis optica (NMO) was first described as a severe monophasic syndrome of acute bilateral optic neuritis and transverse myelitis. Whether it is a form of multiple sclerosis (MS) or a separate disease entity has been continually debated. However, the discovery of NMO-IgG or...

  • Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. Jacob, Anu; McKeon, Andrew; Nakashima, Ichiro; Sato, Douglas Kazutoshi; Elsone, Liene; Fujihara, Kazuo; de Seze, Jerome // Journal of Neurology, Neurosurgery & Psychiatry;Aug2013, Vol. 84 Issue 8, p922 

    Neuromyelitis optica (NMO) has been described as a disease clinically characterised by severe optic neuritis (ON) and transverse myelitis (TM). Other features of NMO include female preponderance, longitudinally extensive spinal cord lesions (>3 vertebral segments), and absence of oligoclonal IgG...

  • Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies. Chang, K-H; Lyu, R-K; Chen, C-M; Wu, Y-R; Chang, H-S; Huang, C-C; Kuo, H-C; Chu, C-C; Hsu, W-C; Ro, L-S // Multiple Sclerosis Journal;Mar2013, Vol. 19 Issue 3, p299 

    The article discusses research which examines the role of anti-aquaporin 4 (anti-AQP4) antibody in the conversion of longitudinally extensive transverse myelitis (LETM) to neuromyelitis optica (NMO). The study retrospectively analyzed thirty patients with LETM and divided into two group...

  • Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders. Tzartos, John S.; Stergiou, Christos; Kilidireas, Konstantinos; Zisimopoulou, Paraskevi; Thomaidis, Thomas; Tzartos, Socrates J. // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Autoantibodies against aquaporin-4 (AQP4), a water channel in CNS astrocytes, are detected in ∼50–80% of patients with neuromyelitis optica spectrum disorders (NMOsd), characterized by longitudinally extensive transverse myelitis (LETM) and/or optic neuritis. Although these...

  • Multiple sclerosis is primarily a neurodegenerative disease. Chaudhuri, Abhijit // Journal of Neural Transmission;Oct2013, Vol. 120 Issue 10, p1463 

    The precise pathogenesis of multiple sclerosis is unknown. The assumption of a primary immunopathogenesis of the disease is seriously flawed and has failed to deliver an effective therapy for most patients. The progressive degeneration of grey and white matter is integral to the natural history...

  • Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica. Weinstock-Guttman, B.; Miller, C.; Yeh, E. A.; Stosic, M.; Umhauer, M.; Batra, N.; Munschauer, F.; Zivadinov, R.; Ramanathan, M. // Multiple Sclerosis (13524585);Sep2008, Vol. 14 Issue 8, p1061 

    Objective To determine whether neuromyelitis optica (NMO) immunoglobulin (IgG) antibody status in NMO/Devic's disease patients followed prospectively is persistent or can change relative to the clinical status and/or response to therapy. Design A cross-sectional group of patients with NMO,...

  • Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exécerbations. Takahashi, T.; Miyazawa, I.; Misu, T.; Takano, H.; Nakashima, I.; Fujihara, K.; Tobita, M.; Itoyama, Y. // Journal of Neurology, Neurosurgery & Psychiatry;Sep2008, Vol. 79 Issue 9, p1075 

    Background: Intractable hiccup and nausea (IHN) are unique symptoms in neuromyelitis optica (NMO). Recent studies have strongly suggested that the pathogenesis of NMO is closely associated with anti-aquaporin-4 (AQP4) antibody. However, clinical implications of IHN and the relationship with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics